Signal2026-05-25
openFDA Drug Data

[FDA Approval] XYZAL ALLERGY 24HR (LEVOCETIRIZINE DIHYDROCHLORIDE)

Part of

Phase 2 Clinical Trial Developments

Open primary sourceSee the whole picture